// App-Quantinova.ai

: Does tumour SUVmax predict adverse prognostic features in patients with pancreatic cancer?

Researchers

Presenter

  • E. Mohamed

Principal Investigators

  • B. Sanghera

  • W. Wong

  • C. Halloran

  • P. Ghaneh

Medical Centers

  • Depts of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom

  • East and North Hertfordshire NHS Trust, Lister, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Microphthalmia, syndromic, 9

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved